A randomized controlled trial involving 85 participants, published Monday in Nature Medicine, examined whether training people to activate brain reward pathways could influence immune response to the hepatitis B vaccine. Participants were divided into three groups: reward mesolimbic upregulation, non-mesolimbic control upregulation and no neurofeedback control.
Study: Brain Reward Training May Boost Vaccine Antibody Response